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Objective-Natriuretic peptide signaling is important in the regulation of blood pressure as well as in the growth of multiple cell types. To examine the role of natriuretic peptide signaling in atherosclerosis, we crossbred mice that lack natriuretic peptide receptor A (NPRA; Npr1 -/-) with atherosclerosis-prone mice that lack apolipoprotein E (apoE; Apoe -/-). Key Words: natriuretic peptide receptor A Ⅲ atherosclerosis Ⅲ cardiac hypertrophy Ⅲ vascular smooth muscle cells T he natriuretic peptide system plays a critical role in regulating blood volume and blood pressure (BP). 1,2 Atrial natriuretic peptide (ANP) and B-type natriuretic peptide are released mainly from the heart after wall stretch and act through natriuretic peptide receptor A (NPRA) in the kidneys and vasculature to induce natriuresis, diuresis, and vasorelaxation. 1, 3, 4 The importance of the natriuretic system in the etiology of hypertension is demonstrated in mice lacking NPRA (Npr1 -/-mice), which have higher than normal BPs. [5] [6] [7] Considerable evidence suggests that elevated BP might have a direct role in enhancing atherosclerotic lesion formation. 8, 9 In addition to the endocrine function in BP control, natriuretic peptides released from the heart also act in an autocrine/paracrine loop to inhibit hypertrophic growth of cardiac myocytes. 10 -12 In Npr1 -/-mice, NPR signaling is absent, leading to a marked enhancement of cardiac hypertrophy that is independent of BP. 11, 13, 14 Expression of ANP and B-type NP has also been detected in the vasculature, 15 and in vitro evidence suggests that extracardiac autocrine/ paracrine NP signaling might negatively regulate hypertrophic growth of both endothelial cells and vascular smooth muscle cells (VSMCs). 16, 17 Thus, through both endocrine and local functions, NPs likely play a role in the pathogenesis of atherosclerosis, and the NPR1 locus is therefore a potential candidate as a genetic risk factor for atherosclerosis.
Methods and Results-Doubly deficient
Proving a direct causal role of mutations in a candidate gene in the pathogenesis of atherosclerosis is complicated by the homeostatic mechanisms that control BP, which might also play a role in atheroma formation. Mouse genetics is a powerful approach to elucidate the causeeffect relation behind hypertension and atherosclerosis and the interaction between these 2 pathological processes. Previously, we have shown that a lack of endothelial nitric oxide synthase results in increased BP and atherosclerotic plaque size in mice deficient for apolipoprotein E (apoE; Apoe -/-mice) that spontaneously develop atherosclerosis. 18 
Plasma Analyses
Plasma ANP level was measured by radioimmunoassay as previously described, 8 and total cholesterol and triglycerides were measured by colorimetric assay (Sigma). HDL cholesterol was measured after removing apoB-containing lipoproteins by precipitation with polyethylene glycol. Plasma creatinine was measured by using a VT250 chemical analyzer (Johnson & Johnson).
BP Analysis
BPs were measured by the noninvasive tail-cuff method 20 on conscious, restrained mice 3 to 4 months of age. The BP of each mouse was the average of the daily means of 6 consecutive days measured with two machines, each with 4 channels (Visitech). Each mouse was subjected to a total of 40 inflations (4 trials of 10 inflations) per day on a different channel each day. The first trial of 10 inflations allowed the mouse to warm up and acclimate to the cuff; these data were discarded. Data from the next 3 trials, each of 10 inflations, were recorded. Daily means were calculated from the means of the 3 trials per day.
Atherosclerotic Lesion Analysis
Animals were euthanized with an overdose of 2,2,2-tribromoethanol at 4 months of age, and the vascular tree was perfused either with 4% paraformaldehyde in phosphate-buffered saline or with phosphatebuffered saline under physiological pressure. Segments of the aortic sinus were embedded, sectioned, and stained as described previously. 21 Plaque size was measured with NIH IMAGE, version 1.59, and the average of the 4 sections chosen by strict anatomic criteria was taken as the mean lesion size for each animal. To evaluate plaque formation in other parts of the aorta, the aortic tree was dissected free of surrounding tissue and examined under a dissection microscope.
Media Thickness of Aorta and Cardiac Mass Measurements
Cross sections of aorta immediately superior to the aortic sinus and containing no atherosclerotic plaques were used to measure the thickness of the tunica media of the ascending aorta of each animal. Medial area was determined by tracing the area between the internal elastic lamina and external elastic lamina of the vessel with NIH IMAGE, version 1.59, to represent the average wall thickness. For cardiac mass measurements, hearts were excised after whole-body perfusion, blotted dry, and weighed. Apoe ϩ/ϩ mice. Thus, the Npr1 genotype-dependent death was limited to a window soon after birth, but its cause was not evident in either gross or histologic examination of 1-to 3-day-old pups (not shown).
Statistical Analysis
Npr1
- 
-/-Apoe -/-Mice Have Increased Medial Thickness of the Aorta Examination of the aorta proximal to the aortic sinus revealed that Npr1 -/-Apoe -/-mice had thicker aortic walls than did Npr1 ϩ/ϩ Apoe -/-mice. The increase in wall thickness of the tunica media was pervasive and largely uniform throughout all 360°of the sectioned aorta and was due to marked hypertrophy of VSMCs (Figure 3, E and F) .
The aortic sections free of noticeable atherosclerotic plaques were used for morphometric analysis. Ascending aortas of Npr1 -/-Apoe -/-mice had larger medial areas than did those of 
ϩ/ϩ Apoe -/-mice (PϽ0.0001, Figure 2B ). There appeared to be a threshold rather than a gene-dosage effect of the Npr1 genotype, because Figure 2B ).
Both Npr1 -/-and Apoe -/-Contribute to Cardiac Hypertrophy in Adult Mice
Consistent with our earlier observation that Npr1 -/-mice had significant cardiac hypertrophy, 11 
Npr1
-/-Apoe -/-mice had increased cardiac mass compared with Npr1 ϩ/ϩ Apoe -/-mice, as determined by their HW/BW at 4 months of age (PϽ0.0001, Figure 4A ). There was also an Npr1 gene-dosage effect, because cardiac mass in (10) 75Ϯ13 (10) 28Ϯ4 (4) 7.9Ϯ0.3 (17) 43Ϯ1 (4) 35Ϯ3 (10) Females 23Ϯ0.6 (16) 410Ϯ16 (7) 51Ϯ3 (7) 26Ϯ3 (6) 7.4Ϯ3.2 (20) (5) 59Ϯ9 (5) 18Ϯ2 (5) 8.2Ϯ0.4 (5) 44Ϯ2 (4) 31Ϯ4 (4) Females 23Ϯ0.3 (4) 331Ϯ47 (5) 46Ϯ6 (5) 22Ϯ5 (4) Data are meanϮSE. Animals were between 4 and 9 months old. The numbers of animals are in parentheses. Effects of genotype and sex were analyzed by using two-way ANOVA. NS indicates not significant. was no difference in plasma creatinine levels, indicating that their renal function was normal (Table 1 ).
Discussion
Our genetic approach revealed that the lack of Npr1 increases BP, atherosclerotic lesion size, and aortic medial area in Apoe -/-mice. Given that atherosclerosis is increased in mice with hypertension from other causes, 18, [22] [23] [24] [25] increased BP likely contributes to atherogenesis in Npr1 -/-Apoe -/-mice. However, because NPRA has intrinsic growth-inhibitory and antimigratory properties in vitro in endothelial cells and VSMCs, 26, 27 enhanced atherosclerosis in Npr1 -/-Apoe -/-mice could be due to the loss of local NP signaling. Casco et al 15 have reported increased expression of all 3 NPs and their receptors, except for NPRA in human coronary arteries with atherosclerosis. These observations support a possibility that an enhanced NP system is actively modulating the progression of atherosclerosis. We found that circulating ANP levels were higher in Npr1 -/-Apoe -/-mice than in Npr1 ϩ/ϩ Apoe -/-mice ( Figure 1B ) and therefore, that NP signaling through receptors other than NPRA might be enhanced in the Npr1 -/-Apoe -/-aorta. Despite this possible enhancement, however, atherosclerosis was increased in Npr1 -/-Apoe -/-mice. Because of a high incidence of postnatal death of Npr1 -/-Apoe -/-mice, we were unable to investigate the relative contributions of the physical BP effects and the direct effects of lack of NPRA in the aorta to the enhanced atherosclerosis in these mice. Mice with SMC-selective deletion of Npr1, such as those recently reported, 28 could help dissociate the direct and indirect effects on atherosclerosis of the lack of NPRA.
We were also interested in the effects of heterozygous loss of the Npr1 gene, because a quantitative reduction in NPRA function is more likely than is a total loss of function in the human population. We found that neither BP nor plaque size differed significantly between Npr1 ϩ/-Apoe -/-and Npr1 ϩ/ϩ Apoe -/-mice. Nevertheless, analysis of the 34 mice (16 females and 18 males) in which BP was also measured indicates that the BP of individual animals and their sex together contributed approximately equally to 48% of the overall variance in lesion size (PϽ0.0001 for sex effect, PϽ0.0005 for BP effect). The regression analysis in Figure 5 shows that BP explains Ϸ30% of the variance in lesion size within females as well as within males. A substantial proportion of the variance remains unaccounted for. Plasma cholesterol levels and heart rates did not contribute significantly to the lesion size variance among these mice. Other potential factors include birth weight, litter size, and seasonal changes, but these were not tested. Intima-media thickening of the aorta and other large vessels is associated with hypertension in humans and is an indicator of future cardiovascular events, including those linked to atherosclerosis. 29, 30 It is unlikely, however, that the increased wall thickness seen in Npr1 -/-mice is due solely to increased BP, and indeed, there were no significant contributions of BP to the wall thickness variance in individual animals among the Npr1
Apoe
-/-and Npr1 ϩ/ϩ Apoe -/-mice (nϭ17). In humans, a BP elevation of 25 mm Hg above normal is associated with increased carotid intima-media thickness of only 6% to 19%. 31, 32 By contrast, our Npr1 -/-Apoe -/-mice had a roughly 59% greater medial thickness than did Npr1 ϩ/ϩ Apoe -/-mice with a 10 -mm Hg difference in BP. As suggested in vitro 26, 27 but not confirmed in vivo, lack of antihypertrophic autocrine/paracrine signaling in aortic SMCs likely contributes to the observed increase in medial area of Npr1 -/-Apoe -/-mice. The extracardiac role for antihypertrophic NPRA signaling highlights the importance of this molecule in the growth control of VSMCs. Previous data have shown that NP signaling can negatively regulate the hypertrophic growth of cardiomyocytes in vitro, 10 and the lack of NPRA increases cardiac hypertrophy. 5, 7, 13 Our study confirms these effects of Npr1 on cardiac hypertrophy on both wild-type and Apoe -/-backgrounds. Recent human studies have found an association between left ventricular hypertrophy and intimamedia thickness of the carotid and femoral arteries that is independent of BP. 33, 34 Our data indicate that the Npr1 gene, though likely not alone in this category, could represent a link between these 2 associated conditions in humans. In fact, a BP-independent link between atherosclerosis and cardiac hypertrophy has been proposed to involve the progrowth activity of angiotensin II, 35 against which natriuretic signaling could act in both VSMCs and cardiomyocytes.
In addition to the effects of NPRA on cardiac hypertrophy, our results also indicate a potential role of apoE in the development of cardiac hypertrophy. Although Apoe -/-mice are more susceptible than wild-type mice to cardiac hypertrophy induced by chronic constriction of the aorta 28 and relatively small increases of their cardiac mass with age have been observed, 36, 37 the current study is the first to demonstrate a direct Apoe -/-genotype effect on cardiac hypertrophy that is synergistic with the effect of NPRA. Given the importance of apoE in lipid transport, apoE might exert its effects directly on the heart, facilitating fatty acid uptake and oxidation, the primary means of energy production in the postfetal heart. 38 Supporting this possibility, cardiac hypertrophy in Apoe -/-mice is not observed by 5 days of age (at or just before the energy production shift) but manifests only after the heart increases its demand for fatty acids. Alternatively, the observed Apoe genotype effect on cardiac mass might be not due to Apoe itself but to 129/Oladerived genes that are closely linked to Apoe and differ functionally from their C57BL/6 counterparts. Genes for dystrophia myotonica-protein kinase, calmodulin 3, and cardiac troponin I are among the potential candidates. In either case, the observed synergistic effect on cardiac hypertrophy in Npr1 -/-Apoe -/-mice 
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is likely due to growth stimuli that cannot be curtailed by NP signaling. Further work is required to determine the mechanisms behind the Apoe genotype effects on cardiac hypertrophy suggested by our genetic models.
In conclusion, our results from mice deficient in apoE and NPRA indicate that quantitative changes in functional Npr1 gene expression in humans could enhance atherosclerosis as well as cardiac hypertrophy. They also suggest that genetic alterations in the Apoe gene could enhance not only atherogenesis but also cardiac hypertrophy through as-yet-undetermined mechanisms.
